XML 31 R22.htm IDEA: XBRL DOCUMENT v3.4.0.3
Nature of Business and Basis of Presentation - Additional Information (Detail)
Patient in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2016
USD ($)
Segment
Patient
Employee
Dec. 31, 2015
USD ($)
Mar. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]        
Number of operating segments | Segment 1      
REDUCE-IT study, number of patients enrolled | Patient 8      
Cash and cash equivalents | $ $ 81,363 $ 106,961 $ 161,195 $ 119,539
Co-Promotion Agreement (the Agreement) | Kowa Pharmaceuticals America        
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]        
Number of sales professionals 150      
Number of sales representatives 250      
Convertible Debt | 2012 Notes        
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]        
Convertible senior notes, earliest redemption date Jan. 19, 2017      
Convertible Debt | 2014 Notes        
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]        
Convertible senior notes, earliest redemption date Jan. 19, 2019      
Convertible Debt | 2015 Notes        
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]        
Convertible senior notes, earliest redemption date Jan. 19, 2019